Abstract
Cancer is the leading cause of deaths worldwide due to their complexity, diversity, risk of reoccurrence, and limited therapeutic options, which are further hindered by the potential side effects. Moreover, the limited potential of detection tools lead to the severity of different types of cancers. An early detection definitely increases the chances of recovery and survival rates. To this end, microbiome, representing the collection of all microorganisms and their genes that live on and inside the body, is recognized as an important player in the diagnosis of different types of cancers. Different well-studied human microbiomes mainly comprising of different bacteria have potential etiological roles in carcinogenesis and/or modulating the individual response to therapies. This chapter provides the current knowledge on different healthy microbiome of different parts of the body and how it is altered during the development of different types of cancers. Specifically, it discusses the microbiome of intestine, oral, lung, vagina, gut, uterus, skin, etc. and their role as biomarkers for the detection of colorectal, pancreatic, liver, breast, lung, cervical, oral and oropharyngeal, and skin cancers. We also provided the current knowledge of microbiota-based therapeutics and management of different types of cancers through different therapies.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Aas JA et al (2005) Defining the normal bacterial flora of the oral cavity. J Clin Microbiol 43(11):5721–5732. https://doi.org/10.1128/JCM.43.11.5721-5732.2005
Ackerman AL, Chai TC (2019) The bladder is not sterile: an update on the urinary microbiome. Curr Bladder Dysfunct Rep 14(4):331–341. https://doi.org/10.1007/s11884-019-00543-6
Adamska A, Domenichini A, Falasca M (2017) Pancreatic ductal adenocarcinoma: current and evolving therapies. Int J Mol Sci 18(7):1338. https://doi.org/10.3390/ijms18071338
Agrawal V, Hirsch E (2012) Intrauterine infection and preterm labor. Semin Fetal Neonatal Med 17(1):12–19. https://doi.org/10.1016/j.siny.2011.09.001
Al-Ahmad A et al (2009) Bacterial colonization of enamel in situ investigated using fluorescence in situ hybridization. J Med Microbiol 58(Pt 10):1359–1366. https://doi.org/10.1099/jmm.0.011213-0
Al-Ahmad A et al (2010) Biofilm formation and composition on different implant materials in vivo. J Biomed Mater Res B Appl Biomater 95(1):101–109. https://doi.org/10.1002/jbm.b.31688
Alaluusua S, Asikainen S, Lai CH (1991) Intrafamilial transmission of Actinobacillus actinomycetemcomitans. J Periodontol 62(3):207–210. https://doi.org/10.1902/jop.1991.62.3.207
Andolfi C et al (2020) The urinary microbiome and bladder cancer: susceptibility and immune responsiveness. Bladder Cancer 6(3):225–235. https://doi.org/10.3233/BLC-200277
Anwar H, Strap JL, Costerton JW (1992) Establishment of aging biofilms: possible mechanism of bacterial resistance to antimicrobial therapy. Antimicrob Agents Chemother 36(7):1347–1351. https://doi.org/10.1128/aac.36.7.1347
Aragón IM et al (2018) The urinary tract microbiome in health and disease. Eur Urol Focus 4(1):128–138. https://doi.org/10.1016/j.euf.2016.11.001
Arthur JC et al (2012) Intestinal inflammation targets cancer-inducing activity of the microbiota. Science 338(6103):120–123. https://doi.org/10.1126/science.1224820
Arweiler NB et al (2014) Action of food preservatives on 14-days dental biofilm formation, biofilm vitality and biofilm-derived enamel demineralisation in situ. Clin Oral Investig 18(3):829–838. https://doi.org/10.1007/s00784-013-1053-9
Attar N (2016) Transgenerational missing taxa. Nat Rev Microbiol 14(3):132–133. https://doi.org/10.1038/nrmicro.2016.11
Auschill TM et al (2002) The effect of dental restorative materials on dental biofilm. Eur J Oral Sci 110(1):48–53. https://doi.org/10.1046/j.0909-8836.2001.101160.x
Bailey MT et al (2011) Exposure to a social stressor alters the structure of the intestinal microbiota: implications for stressor-induced immunomodulation. Brain Behav Immun 25(3):397–407. https://doi.org/10.1016/j.bbi.2010.10.023
Bakadia BM et al (2020) Prevention and treatment of COVID-19: focus on interferons, chloroquine/hydroxychloroquine, azithromycin, and vaccine. Biomed Pharmacother 133:111008. https://doi.org/10.1016/j.biopha.2020.111008
Balows AE et al (2013) The prokaryotes: a handbook on the biology of bacteria: ecophysiology, isolation, identification, applications. Springer Science & Business Media, New York, NY
Baxter NT, Koumpouras CC et al (2016a) DNA from fecal immunochemical test can replace stool for detection of colonic lesions using a microbiota-based model. Microbiome 4(1):59. https://doi.org/10.1186/s40168-016-0205-y
Baxter NT, Ruffin MT et al (2016b) Microbiota-based model improves the sensitivity of fecal immunochemical test for detecting colonic lesions. Genome Med 8(1):37. https://doi.org/10.1186/s13073-016-0290-3
Bi H et al (2019) Urinary microbiota – a potential biomarker and therapeutic target for bladder cancer. J Med Microbiol 68(10):1471–1478. https://doi.org/10.1099/jmm.0.001058
Bik EM et al (2010) Bacterial diversity in the oral cavity of 10 healthy individuals. ISME J 4(8):962–974. https://doi.org/10.1038/ismej.2010.30
Boleij A et al (2015) The Bacteroides fragilis toxin gene is prevalent in the colon mucosa of colorectal cancer patients. Clin Infect Dis 60(2):208–215. https://doi.org/10.1093/cid/ciu787
Börnigen D et al (2017) Alterations in oral bacterial communities are associated with risk factors for oral and oropharyngeal cancer. Sci Rep 7(1):17686. https://doi.org/10.1038/s41598-017-17795-z
Brüssow H (2020) Problems with the concept of gut microbiota dysbiosis. Microb Biotechnol 13(2):423–434. https://doi.org/10.1111/1751-7915.13479
Bučević Popović V et al (2018) The urinary microbiome associated with bladder cancer. Sci Rep 8(1):12157. https://doi.org/10.1038/s41598-018-29054-w
Busscher HJ, van der Mei HC (1997) Physico-chemical interactions in initial microbial adhesion and relevance for biofilm formation. Adv Dent Res 11(1):24–32. https://doi.org/10.1177/08959374970110011301
Carbone C et al (2019) Lung and gut microbiota as potential hidden driver of immunotherapy efficacy in lung cancer. Mediat Inflamm 2019:7652014. https://doi.org/10.1155/2019/7652014
Champer M et al (2018) The role of the vaginal microbiome in gynaecological cancer. BJOG 125(3):309–315. https://doi.org/10.1111/1471-0528.14631
Chao X et al (2020) Research of the potential biomarkers in vaginal microbiome for persistent high-risk human papillomavirus infection. Ann Transl Med 8(4):100–100. https://doi.org/10.21037/atm.2019.12.115
Chase D et al (2015) The vaginal and gastrointestinal microbiomes in gynecologic cancers: a review of applications in etiology, symptoms and treatment. Gynecol Oncol 138(1):190–200. https://doi.org/10.1016/j.ygyno.2015.04.036
Chee WJY, Chew SY, Than LTL (2020) Vaginal microbiota and the potential of Lactobacillus derivatives in maintaining vaginal health. Microb Cell Factories 19(1):203. https://doi.org/10.1186/s12934-020-01464-4
Coker OO et al (2019) Enteric fungal microbiota dysbiosis and ecological alterations in colorectal cancer. Gut 68(4):654–662. https://doi.org/10.1136/gutjnl-2018-317178
Cruchley AT et al (1989) Regional variation in Langerhans cell distribution and density in normal human oral mucosa determined using monoclonal antibodies against CD1, HLADR, HLADQ and HLADP. J Oral Pathol Med 18(9):510–516. https://doi.org/10.1111/j.1600-0714.1989.tb01353.x
Cuevas-Ramos G et al (2010) Escherichia coli induces DNA damage in vivo and triggers genomic instability in mammalian cells. Proc Natl Acad Sci 107(25):11537–11542. https://doi.org/10.1073/pnas.1001261107
Dabek M et al (2008) Distribution of beta-glucosidase and beta-glucuronidase activity and of beta-glucuronidase gene gus in human colonic bacteria. FEMS Microbiol Ecol 66(3):487–495. https://doi.org/10.1111/j.1574-6941.2008.00520.x
Dahmus JD et al (2018) The gut microbiome and colorectal cancer: a review of bacterial pathogenesis. J Gastrointest Oncol 9(4):769–777. https://doi.org/10.21037/jgo.2018.04.07
Daisley BA et al (2020) Abiraterone acetate preferentially enriches for the gut commensal Akkermansia muciniphila in castrate-resistant prostate cancer patients. Nat Commun 11(1):4822. https://doi.org/10.1038/s41467-020-18649-5
Demuth DR, Savary R, Golub E, Shenker BJ (1996) Identification and analysis of fipA, a Fusobacterium nucleatum immunosuppressive factor gene. Infect Immun 64(4):1335–1341
Desvaux M et al (2005) Protein secretion systems in Fusobacterium nucleatum: genomic identification of Type 4 piliation and complete Type V pathways brings new insight into mechanisms of pathogenesis. Biochim Biophys Acta Biomembr 1713(2):92–112. https://doi.org/10.1016/j.bbamem.2005.05.002
Eklöf V et al (2017) Cancer-associated fecal microbial markers in colorectal cancer detection. Int J Cancer 141(12):2528–2536. https://doi.org/10.1002/ijc.31011
Ethier J-L et al (2017) Prognostic role of neutrophil-to-lymphocyte ratio in breast cancer: a systematic review and meta-analysis. Breast Cancer Res 19(1):2. https://doi.org/10.1186/s13058-016-0794-1
Fan X et al (2018) Human oral microbiome and prospective risk for pancreatic cancer: a population-based nested case-control study. Gut 67(1):120–127. https://doi.org/10.1136/gutjnl-2016-312580
Faner R et al (2017) The microbiome in respiratory medicine: current challenges and future perspectives. Eur Respir J 49(4):1602086. https://doi.org/10.1183/13993003.02086-2016
Faran Ali SM, Tanwir F (2012) Oral microbial habitat a dynamic entity. J Oral Biol Craniofac Res 2(3):181–187. https://doi.org/10.1016/j.jobcr.2012.07.001
Ferlay J et al (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136(5):E359–E386. https://doi.org/10.1002/ijc.29210
Ferreira RM et al (2018) Gastric microbial community profiling reveals a dysbiotic cancer-associated microbiota. Gut 67(2):226–236. https://doi.org/10.1136/gutjnl-2017-314205
Fleming C et al (2017) Microbiota-activated CD103+ DCs stemming from microbiota adaptation specifically drive γδT17 proliferation and activation. Microbiome 5(1):46. https://doi.org/10.1186/s40168-017-0263-9
Flores R et al (2012) Fecal microbial determinants of fecal and systemic estrogens and estrogen metabolites: a cross-sectional study. J Transl Med 10(1):253. https://doi.org/10.1186/1479-5876-10-253
Friedman GD et al (2006) Antibiotics and risk of breast cancer: up to 9 years of follow-up of 2.1 million women. Cancer Epidemiol Biomark Prev 15(11):2102–2106. https://doi.org/10.1158/1055-9965.EPI-06-0401
Fröhlich E et al (2016) Measurements of deposition, lung surface area and lung fluid for simulation of inhaled compounds. Front Pharmacol 7:181. https://doi.org/10.3389/fphar.2016.00181
Fuhrman BJ et al (2014) Associations of the fecal microbiome with urinary estrogens and estrogen metabolites in postmenopausal women. J Clin Endocrinol Metab 99(12):4632–4640. https://doi.org/10.1210/jc.2014-2222
Fürst MM et al (2007) Bacterial colonization immediately after installation on oral titanium implants. Clin Oral Implants Res 18(4):501–508. https://doi.org/10.1111/j.1600-0501.2007.01381.x
Gantuya B et al (2019) Gastric microbiota in helicobacter pylori-negative and -positive gastritis among high incidence of gastric cancer area. Cancers 11(4):504. https://doi.org/10.3390/cancers11040504
Ghoncheh M, Pournamdar Z, Salehiniya H (2016) Incidence and mortality and epidemiology of breast cancer in the world. Asian Pac J Cancer Prev 17(S3):43–46. https://doi.org/10.7314/apjcp.2016.17.s3.43
Gill SR et al (2006) Metagenomic analysis of the human distal gut microbiome. Science 312(5778):1355–1359. https://doi.org/10.1126/science.1124234
Goedert JJ et al (2015) Investigation of the association between the fecal microbiota and breast cancer in postmenopausal women: a population-based case-control pilot study. J Natl Cancer Inst 107(8):djv147. https://doi.org/10.1093/jnci/djv147
Goodwin AC et al (2011) Polyamine catabolism contributes to enterotoxigenic Bacteroides fragilis-induced colon tumorigenesis. Proc Natl Acad Sci 108(37):15354–15359. https://doi.org/10.1073/pnas.1010203108
Govender Y et al (2019) The current evidence on the association between the urinary microbiome and urinary incontinence in women. Front Cell Infect Microbiol 9:133. https://doi.org/10.3389/fcimb.2019.00133
Grice EA, Segre JA (2011) The skin microbiome. Nat Rev Microbiol 9(4):244–253. https://doi.org/10.1038/nrmicro2537
Grice EA et al (2009) Topographical and temporal diversity of the human skin microbiome. Science 324(5931):1190–1192. https://doi.org/10.1126/science.1171700
Gritzapis AD et al (2008) Identification of a novel immunogenic HLA-A*0201-binding epitope of HER-2/neu with potent antitumor properties. J Immunol 181(1):146–154. https://doi.org/10.4049/jimmunol.181.1.146
Gunter MJ et al (2015) Breast cancer risk in metabolically healthy but overweight postmenopausal women. Cancer Res 75(2):270–274. https://doi.org/10.1158/0008-5472.CAN-14-2317
Guo S et al (2018) A simple and novel fecal biomarker for colorectal cancer: ratio of fusobacterium nucleatum to probiotics populations, based on their antagonistic effect. Clin Chem 64(9):1327–1337. https://doi.org/10.1373/clinchem.2018.289728
Gur C et al (2015) Binding of the Fap2 protein of fusobacterium nucleatum to human inhibitory receptor TIGIT protects tumors from immune cell attack. Immunity 42(2):344–355. https://doi.org/10.1016/j.immuni.2015.01.010
Han YW et al (2005) Identification and characterization of a novel adhesin unique to oral fusobacteria. J Bacteriol 187(15):5330–5340. https://doi.org/10.1128/JB.187.15.5330-5340.2005
Hemarajata P, Versalovic J (2013) Effects of probiotics on gut microbiota: mechanisms of intestinal immunomodulation and neuromodulation. Ther Adv Gastroenterol 6(1):39–51. https://doi.org/10.1177/1756283X12459294
Hills RD et al (2019) Gut microbiome: profound implications for diet and disease. Nutrients 11(7):1613. https://doi.org/10.3390/nu11071613
Hourigan SK et al (2020) Studying the urine microbiome in superficial bladder cancer: samples obtained by midstream voiding versus cystoscopy. BMC Urol 20(1):5. https://doi.org/10.1186/s12894-020-0576-z
Huang H et al (2020) Integrated analysis of microbiome and host transcriptome reveals correlations between gut microbiota and clinical outcomes in HBV-related hepatocellular carcinoma. Genome Med 12(1):102. https://doi.org/10.1186/s13073-020-00796-5
Hullar MAJ, Burnett-Hartman AN, Lampe JW (2014) Gut microbes, diet, and cancer. Cancer Treat Res 159:377–399. https://doi.org/10.1007/978-3-642-38007-5_22
Jain A, Kaczanowska S, Davila E (2014) IL-1 receptor-associated kinase signaling and its role in inflammation, cancer progression, and therapy resistance. Front Immunol 5:553. https://doi.org/10.3389/fimmu.2014.00553
Jasperson KW et al (2010) Hereditary and familial colon cancer. Gastroenterology 138(6):2044–2058. https://doi.org/10.1053/j.gastro.2010.01.054
Jefferson RA, Burgess SM, Hirsh D (1986) Beta-glucuronidase from Escherichia coli as a gene-fusion marker. Proc Natl Acad Sci U S A 83(22):8447–8451. https://doi.org/10.1073/pnas.83.22.8447
Kang M, Martin A (2017) Microbiome and colorectal cancer: unraveling host-microbiota interactions in colitis-associated colorectal cancer development. Semin Immunol 32:3–13. https://doi.org/10.1016/j.smim.2017.04.003
Kang D-W et al (2013) Reduced incidence of Prevotella and other fermenters in intestinal microflora of autistic children. PLoS One 8(7):e68322. https://doi.org/10.1371/journal.pone.0068322
Kato MK et al (2021) Brain metastases from uterine cervical and endometrial cancer. Cancers 13(3):519. https://doi.org/10.3390/cancers13030519
Kelleher AM, DeMayo FJ, Spencer TE (2019) Uterine glands: developmental biology and functional roles in pregnancy. Endocr Rev 40(5):1424–1445. https://doi.org/10.1210/er.2018-00281
Kerr WJ, Kelly J, Geddes DA (1991) The areas of various surfaces in the human mouth from nine years to adulthood. J Dent Res 70(12):1528–1530. https://doi.org/10.1177/00220345910700121001
Kilian M et al (2016) The oral microbiome – an update for oral healthcare professionals. Br Dent J 221(10):657–666. https://doi.org/10.1038/sj.bdj.2016.865
Kim JM, Lee JY, Kim Y-J (2008a) Inhibition of apoptosis in Bacteroides fragilis enterotoxin-stimulated intestinal epithelial cells through the induction of c-IAP-2. Eur J Immunol 38(8):2190–2199. https://doi.org/10.1002/eji.200838191
Kim Y et al (2008b) Inhibition of proliferation in colon cancer cell lines and harmful enzyme activity of colon bacteria by Bifidobacterium adolescentis SPM0212. Arch Pharm Res 31(4):468–473. https://doi.org/10.1007/s12272-001-1180-y
Knust Z, Schmidt G (2010) Cytotoxic necrotizing factors (CNFs)–a growing toxin family. Toxins 2(1):116–127. https://doi.org/10.3390/toxins2010116
Könönen E, Conrads G, Nagy E (2015) Bacteroides, porphyromonas, prevotella, fusobacterium, and other anaerobic gram-negative rods. In: Manual of clinical microbiology. ASM Press, Washington, DC, pp 967–993. https://doi.org/10.1128/9781555817381.ch54
Kotilea K et al (2018) Helicobacter pylori infection in pediatric patients: update on diagnosis and eradication strategies. Pediatr Drugs 20(4):337–351. https://doi.org/10.1007/s40272-018-0296-y
Kwa M et al (2016) The intestinal microbiome and estrogen receptor-positive female breast cancer. J Natl Cancer Inst 108(8):djw029. https://doi.org/10.1093/jnci/djw029
Kyrgiou M, Mitra A, Moscicki A-B (2017) Does the vaginal microbiota play a role in the development of cervical cancer? Transl Res 179:168–182. https://doi.org/10.1016/j.trsl.2016.07.004
Laguna TA et al (2016) Airway microbiota in bronchoalveolar lavage fluid from clinically well infants with cystic fibrosis. PLoS One 11(12):e0167649. https://doi.org/10.1371/journal.pone.0167649
Lakritz JR et al (2015) Gut bacteria require neutrophils to promote mammary tumorigenesis. Oncotarget 6(11):9387–9396. https://doi.org/10.18632/oncotarget.3328
Lapidot Y et al (2020) Alterations in the gut microbiome in the progression of cirrhosis to hepatocellular carcinoma. mSystems 5(3). https://doi.org/10.1128/mSystems.00153-20
Le Chatelier E et al (2013) Richness of human gut microbiome correlates with metabolic markers. Nature 500(7464):541–546. https://doi.org/10.1038/nature12506
Lee SH et al (2016) Characterization of microbiome in bronchoalveolar lavage fluid of patients with lung cancer comparing with benign mass like lesions. Lung Cancer 102:89–95. https://doi.org/10.1016/j.lungcan.2016.10.016
Lepor H (2004) Evaluating men with benign prostatic hyperplasia. Rev Urol 6(Suppl 1):S8–S15
Lewis JS et al (2005) Differential effects of 16alpha-hydroxyestrone and 2-methoxyestradiol on cyclin D1 involving the transcription factor ATF-2 in MCF-7 breast cancer cells. J Mol Endocrinol 34(1):91–105. https://doi.org/10.1677/jme.1.01599
Li H et al (2016a) Clinical value of mammography in diagnosis and identification of breast mass. Pak J Med Sci 32(4):1020–1025. https://doi.org/10.12669/pjms.324.9384
Li N, Xie C, Lu N-H (2016b) p53, a potential predictor of Helicobacter pylori infection-associated gastric carcinogenesis? Oncotarget 7(40):66276–66286. https://doi.org/10.18632/oncotarget.11414
Li TH et al (2017) Alterations in gastric microbiota after H. Pylori eradication and in different histological stages of gastric carcinogenesis. Sci Rep 7(1):44935. https://doi.org/10.1038/srep44935
Liang Q et al (2017) Fecal bacteria act as novel biomarkers for noninvasive diagnosis of colorectal cancer. Clin Cancer Res 23(8):2061–2070. https://doi.org/10.1158/1078-0432.CCR-16-1599
Liu F et al (2017) Characterization of the urinary microbiota of elderly women and the effects of type 2 diabetes and urinary tract infections on the microbiota. Oncotarget 8(59):100678–100690. https://doi.org/10.18632/oncotarget.21126
Liu H-X et al (2018) Difference of lower airway microbiome in bilateral protected specimen brush between lung cancer patients with unilateral lobar masses and control subjects. Int J Cancer 142(4):769–778. https://doi.org/10.1002/ijc.31098
Liu N-N et al (2020a) Microbiome dysbiosis in lung cancer: from composition to therapy. NPJ Precis Oncol 4(1):33. https://doi.org/10.1038/s41698-020-00138-z
Liu X et al (2020b) Helicobacter pylori infection induced genome instability and gastric cancer. Genome Instabil Dis 1(3):129–142. https://doi.org/10.1007/s42764-020-00010-1
Liu-Smith F, Jia J, Zheng Y (2017) UV-induced molecular signaling differences in melanoma and non-melanoma skin cancer. Adv Exp Med Biol 996:27–40. https://doi.org/10.1007/978-3-319-56017-5_3
Loverdos K et al (2019) Lung microbiome in asthma: current perspectives. J Clin Med 8(11):1967. https://doi.org/10.3390/jcm8111967
Lu H et al (2019) Tongue coating microbiome data distinguish patients with pancreatic head cancer from healthy controls. J Oral Microbiol 11(1):1563409. https://doi.org/10.1080/20002297.2018.1563409
Lv G, Cheng N, Wang H (2017) The gut microbiota, tumorigenesis, and liver diseases. Engineering 3(1):110–114. https://doi.org/10.1016/J.ENG.2017.01.017
Ma C et al (2018) Gut microbiome–mediated bile acid metabolism regulates liver cancer via NKT cells. Science 360(6391):eaan5931. https://doi.org/10.1126/science.aan5931
Macpherson AJ, Harris NL (2004) Interactions between commensal intestinal bacteria and the immune system. Nat Rev Immunol 4(6):478–485. https://doi.org/10.1038/nri1373
Madigan MT, Martinko J (2005) Brock biology of microorganisms. Pearson Prentice Hall, Upper Saddle River, NJ, pp 149–152
Madigan MT, Martinko JM, Parker J (1997) Brock biology of microorganisms. Prentice Hall, Upper Saddle River, NJ, p 11
Mao Q et al (2018) Interplay between the lung microbiome and lung cancer. Cancer Lett 415:40–48. https://doi.org/10.1016/j.canlet.2017.11.036
Mattar MC et al (2011) Current management of inflammatory bowel disease and colorectal cancer. Gastrointest Cancer Res 4(2):53–61
Matteson KA, Robison K, Jacoby VL (2018) Opportunities for early detection of endometrial cancer in women with postmenopausal bleeding. JAMA Intern Med 178(9):1222. https://doi.org/10.1001/jamainternmed.2018.2819
McHardy IH et al (2013) HIV infection is associated with compositional and functional shifts in the rectal mucosal microbiota. Microbiome 1(1):26. https://doi.org/10.1186/2049-2618-1-26
Michaud DS, Izard J (2014) Microbiota, oral microbiome, and pancreatic cancer. Cancer J 20(3):203–206. https://doi.org/10.1097/PPO.0000000000000046
Mitra A et al (2016) The vaginal microbiota, human papillomavirus infection and cervical intraepithelial neoplasia: what do we know and where are we going next? Microbiome 4(1):58. https://doi.org/10.1186/s40168-016-0203-0
Molina N et al (2020) New opportunities for endometrial health by modifying uterine microbial composition: present or future? Biomolecules 10(4):593. https://doi.org/10.3390/biom10040593
Moo T-A et al (2018) Overview of breast cancer therapy. PET Clin 13(3):339–354. https://doi.org/10.1016/j.cpet.2018.02.006
Moore SC et al (2016) Endogenous estrogens, estrogen metabolites, and breast cancer risk in postmenopausal chinese women. J Natl Cancer Inst 108(10):djw103. https://doi.org/10.1093/jnci/djw103
Moss SF (2017) The clinical evidence linking helicobacter pylori to gastric cancer. Cell Mol Gastroenterol Hepatol 3(2):183–191. https://doi.org/10.1016/j.jcmgh.2016.12.001
Myers LL, Shoop DS, Stackhouse LL, Newman FS, Flaherty RJ, Letson GW, Sack RB (1987) Isolation of enterotoxigenic Bacteroides fragilis from humans with diarrhea. J Clin Microbiol 25(12):2330–2333
Nakatsu G et al (2018) Alterations in enteric virome are associated with colorectal cancer and survival outcomes. Gastroenterology 155(2):529–541.e5. https://doi.org/10.1053/j.gastro.2018.04.018
Nakatsuji T et al (2013) The microbiome extends to subepidermal compartments of normal skin. Nat Commun 4(1):1431. https://doi.org/10.1038/ncomms2441
Nakatsuji T et al (2018) A commensal strain of Staphylococcus epidermidis protects against skin neoplasia. Sci Adv 4:eaao4502
Niederreiter L, Adolph TE, Tilg H (2018) Food, microbiome and colorectal cancer. Dig Liver Dis 50(7):647–652. https://doi.org/10.1016/j.dld.2018.03.030
NIH HMP Working Group et al (2009) The NIH human microbiome project. Genome Res 19(12):2317–2323. https://doi.org/10.1101/gr.096651.109
Ogunwobi OO, Mahmood F, Akingboye A (2020) Biomarkers in colorectal cancer: current research and future prospects. Int J Mol Sci 21(15):5311. https://doi.org/10.3390/ijms21155311
Osefo N, Ito T, Jensen RT (2009) Gastric acid hypersecretory states: recent insights and advances. Curr Gastroenterol Rep 11(6):433–441. https://doi.org/10.1007/s11894-009-0067-6
Pacifico L et al (2010) Consequences of Helicobacter pylori infection in children. World J Gastroenterol 16(41):5181–5194. https://doi.org/10.3748/wjg.v16.i41.5181
Paster BJ et al (2006) The breadth of bacterial diversity in the human periodontal pocket and other oral sites. Periodontol 42(1):80–87. https://doi.org/10.1111/j.1600-0757.2006.00174.x
Piñero F et al (2019) A different gut microbiome linked to inflammation found in cirrhotic patients with and without hepatocellular carcinoma. Ann Hepatol 18(3):480–487. https://doi.org/10.1016/j.aohep.2018.10.003
Plottel CS, Blaser MJ (2011) Microbiome and malignancy. Cell Host Microbe 10(4):324–335. https://doi.org/10.1016/j.chom.2011.10.003
Pohl HG et al (2020) The urine microbiome of healthy men and women differs by urine collection method. Int Neurourol J 24(1):41–51. https://doi.org/10.5213/inj.1938244.122
Ponziani FR et al (2019) Hepatocellular carcinoma is associated with gut microbiota profile and inflammation in nonalcoholic fatty liver disease. Hepatology 69(1):107–120. https://doi.org/10.1002/hep.30036
Pushalkar S et al (2018) The pancreatic cancer microbiome promotes oncogenesis by induction of innate and adaptive immune suppression. Cancer Discov 8(4):403–416. https://doi.org/10.1158/2159-8290.CD-17-1134
Qi Y et al (2019) Intestinal microbiota is altered in patients with gastric cancer from Shanxi Province, China. Dig Dis Sci 64(5):1193–1203. https://doi.org/10.1007/s10620-018-5411-y
Ramchander N, Crosbie E (2018) The vaginal microbiome and gynaecological cancer: exercise caution when considering causation. BJOG 125(3):316–316. https://doi.org/10.1111/1471-0528.14704
Rao B-C et al (2020) Human microbiome is a diagnostic biomarker in hepatocellular carcinoma. Hepatobil Panc Dis Int 19(2):109–115. https://doi.org/10.1016/j.hbpd.2020.01.003
Raptis D et al (2015) The differential diagnosis and interdisciplinary treatment of anal carcinoma. Deutsches Aerzteblatt Online 112:243. https://doi.org/10.3238/arztebl.2015.0243
Rawla P, Barsouk A (2019) Epidemiology of gastric cancer: global trends, risk factors and prevention. Gastroenterol Rev 14(1):26–38. https://doi.org/10.5114/pg.2018.80001
Rawla P, Sunkara T, Gaduputi V (2019b) Epidemiology of pancreatic cancer: global trends, etiology and risk factors. World J Oncol 10(1):10–27. https://doi.org/10.14740/wjon1166
Raza M, Bhatt H (2020) Atrophic gastritis. StatPearls, Treasure Island, FL
Ren Z et al (2019) Gut microbiome analysis as a tool towards targeted non-invasive biomarkers for early hepatocellular carcinoma. Gut 68(6):1014–1023. https://doi.org/10.1136/gutjnl-2017-315084
Roh JS, Sohn DH (2018) Damage-associated molecular patterns in inflammatory diseases. Immune Netw 18(4):e27. https://doi.org/10.4110/in.2018.18.e27
Rubinstein MR et al (2013) Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin/β-catenin signaling via its FadA adhesin. Cell Host Microbe 14(2):195–206. https://doi.org/10.1016/j.chom.2013.07.012
Russo J, Russo IH (2006) The role of estrogen in the initiation of breast cancer. J Steroid Biochem Mol Biol 102(1–5):89–96. https://doi.org/10.1016/j.jsbmb.2006.09.004
Sampsell K, Hao D, Reimer RA (2020) The gut microbiota: a potential gateway to improved health outcomes in breast cancer treatment and survivorship. Int J Mol Sci 21(23):9239. https://doi.org/10.3390/ijms21239239
Sampson JN et al (2017) Association of estrogen metabolism with breast cancer risk in different cohorts of postmenopausal women. Cancer Res 77(4):918–925. https://doi.org/10.1158/0008-5472.CAN-16-1717
Sánchez-Alcoholado L et al (2020) The role of the gut microbiome in colorectal cancer development and therapy response. Cancers 12(6):1406. https://doi.org/10.3390/cancers12061406
Saus E et al (2019) Microbiome and colorectal cancer: roles in carcinogenesis and clinical potential. In: Molecular aspects of medicine. Elsevier Ltd, Amsterdam, pp 93–106. https://doi.org/10.1016/j.mam.2019.05.001
Schwiertz A (ed) (2016) Microbiota of the human body (Advances in experimental medicine and biology). Springer International Publishing, Cham. https://doi.org/10.1007/978-3-319-31248-4
Seite S, Bieber T (2015) Barrier function and microbiotic dysbiosis in atopic dermatitis. Clin Cosmet Investig Dermatol 8:479–483. https://doi.org/10.2147/CCID.S91521
Sender R, Fuchs S, Milo R (2016) Are we really vastly outnumbered? Revisiting the ratio of bacterial to host cells in humans. Cell 164(3):337–340. https://doi.org/10.1016/j.cell.2016.01.013
Sharifi H et al (2019) Burden of obstructive lung disease study in Iran: first report of the prevalence and risk factors of copd in five provinces. Lung India 36(1):14–19. https://doi.org/10.4103/lungindia.lungindia_129_18
Shen XJ et al (2010) Molecular characterization of mucosal adherent bacteria and associations with colorectal adenomas. Gut Microbes 1(3):138–147. https://doi.org/10.4161/gmic.1.3.12360
Shen W et al (2020) Microbiome in intestinal lavage fluid may be a better indicator in evaluating the risk of developing colorectal cancer compared with fecal samples. Transl Oncol 13(5):100772. https://doi.org/10.1016/j.tranon.2020.100772
Shenker BJ, Datar S (1995) Fusobacterium nucleatum inhibits human T-cell activation by arresting cells in the mid-G1 phase of the cell cycle. Infect Immun 63(12):4830–4836
Shrestha E et al (2018) Profiling the urinary microbiome in men with positive versus negative biopsies for prostate cancer. J Urol 199(1):161–171. https://doi.org/10.1016/j.juro.2017.08.001
Siddiqui H et al (2014) Pathogens in urine from a female patient with overactive bladder syndrome detected by culture-independent high throughput sequencing: a case report. Open Microbiol J 8:148–153. https://doi.org/10.2174/1874285801408010148
Sivan A et al (2015) Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy. Science (New York, NY) 350(6264):1084–1089. https://doi.org/10.1126/science.aac4255
Sobhani I et al (2019) Colorectal cancer-associated microbiota contributes to oncogenic epigenetic signatures. Proc Natl Acad Sci 116(48):24285–24295. https://doi.org/10.1073/pnas.1912129116
Socransky SS et al (1963) The microbiota of the gingival crevice area of man—I. Arch Oral Biol 8(3):275–280. https://doi.org/10.1016/0003-9969(63)90019-0
Song M, Chan AT, Sun J (2020) Influence of the gut microbiome, diet, and environment on risk of colorectal cancer. Gastroenterology 158(2):322–340. https://doi.org/10.1053/j.gastro.2019.06.048
Stewart OA, Wu F, Chen Y (2020) The role of gastric microbiota in gastric cancer. Gut Microbes 11(5):1220–1230. https://doi.org/10.1080/19490976.2020.1762520
Suehiro Y et al (2018) Highly sensitive faecal DNA testing of TWIST1 methylation in combination with faecal immunochemical test for haemoglobin is a promising marker for detection of colorectal neoplasia. Ann Clin Biochem 55(1):59–68. https://doi.org/10.1177/0004563217691064
Sun H et al (2020) Characterization of oral microbiome and exploration of potential biomarkers in patients with pancreatic cancer. Biomed Res Int 2020:1–11. https://doi.org/10.1155/2020/4712498
Tamim M, H. et al (2008) Risk of breast cancer in relation to antibiotic use. Pharmacoepidemiol Drug Saf 17(2):144–150. https://doi.org/10.1002/pds.1512
Temraz S et al (2019) Gut microbiome: a promising biomarker for immunotherapy in colorectal cancer. Int J Mol Sci 20(17):4155. https://doi.org/10.3390/ijms20174155
Tenaillon O et al (2010) The population genetics of commensal Escherichia coli. Nat Rev Microbiol 8(3):207–217. https://doi.org/10.1038/nrmicro2298
Thomas AM et al (2019) Metagenomic analysis of colorectal cancer datasets identifies cross-cohort microbial diagnostic signatures and a link with choline degradation. Nat Med 25(4):667–678. https://doi.org/10.1038/s41591-019-0405-7
Usyk M et al (2020) Cervicovaginal microbiome and natural history of HPV in a longitudinal study. PLoS Pathog 16(3):e1008376. https://doi.org/10.1371/journal.ppat.1008376
Velicer CM (2004) Antibiotic use in relation to the risk of breast cancer. JAMA 291(7):827. https://doi.org/10.1001/jama.291.7.827
Verstraelen H et al (2016) Characterisation of the human uterine microbiome in non-pregnant women through deep sequencing of the V1-2 region of the 16S rRNA gene. PeerJ 4:e1602. https://doi.org/10.7717/peerj.1602
Vizcaino MI, Crawford JM (2015) The colibactin warhead crosslinks DNA. Nat Chem 7(5):411–417. https://doi.org/10.1038/nchem.2221
Walsh DM et al (2019) Postmenopause as a key factor in the composition of the Endometrial Cancer Microbiome (ECbiome). Sci Rep 9(1):19213. https://doi.org/10.1038/s41598-019-55720-8
Walther-António MRS et al (2016) Potential contribution of the uterine microbiome in the development of endometrial cancer. Genome Med 8(1):122. https://doi.org/10.1186/s13073-016-0368-y
Wang Y et al (2011) Altered protein expression in serum from endometrial hyperplasia and carcinoma patients. J Hematol Oncol 4(1):15. https://doi.org/10.1186/1756-8722-4-15
Wang ZK et al (2014) Review article: fungal microbiota and digestive diseases. Aliment Pharmacol Ther 39(8):751–766. https://doi.org/10.1111/apt.12665
Watanabe S, Dawes C (1990) Salivary flow rates and salivary film thickness in five-year-old children. J Dent Res 69(5):1150–1153. https://doi.org/10.1177/00220345900690050601
Wei M-Y et al (2019) The microbiota and microbiome in pancreatic cancer: more influential than expected. Mol Cancer 18(1):97. https://doi.org/10.1186/s12943-019-1008-0
Wieczorska K, Stolarek M, Stec R (2020) The role of the gut microbiome in colorectal cancer: where are we? Where are we going? Clin Colorectal Cancer 19(1):5–12. https://doi.org/10.1016/j.clcc.2019.07.006
Williams AB, Schumacher B (2016) p53 in the DNA-damage-repair process. Cold Spring Harb Perspect Med 6(5):a026070. https://doi.org/10.1101/cshperspect.a026070
Winters AD et al (2019) Does the endometrial cavity have a molecular microbial signature? Sci Rep 9(1):9905. https://doi.org/10.1038/s41598-019-46173-0
Wong SH, Yu J (2019) Gut microbiota in colorectal cancer: mechanisms of action and clinical applications. Nat Rev Gastroenterol Hepatol 16(11):690–704. https://doi.org/10.1038/s41575-019-0209-8
Wong SH et al (2017) Quantitation of faecal Fusobacterium improves faecal immunochemical test in detecting advanced colorectal neoplasia. Gut 66(8):1441–1448. https://doi.org/10.1136/gutjnl-2016-312766
Wouters EFM (2019) The lung-gut-cross talk in chronic airways diseases. Barcelona Resp Netw 5(1). https://doi.org/10.23866/BRNRev:2018-0020
Wroblewski LE, Peek RM, Wilson KT (2010) Helicobacter pylori and gastric cancer: factors that modulate disease risk. Clin Microbiol Rev 23(4):713–739. https://doi.org/10.1128/CMR.00011-10
Wu H-J, Wu E (2012) The role of gut microbiota in immune homeostasis and autoimmunity. Gut Microbes 3(1):4–14. https://doi.org/10.4161/gmic.19320
Wu S et al (2009) A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses. Nat Med 15(9):1016–1022. https://doi.org/10.1038/nm.2015
Wu P et al (2018) Profiling the urinary microbiota in male patients with bladder cancer in China. Front Cell Infect Microbiol 8:167. https://doi.org/10.3389/fcimb.2018.00167
Xie Y-H et al (2017) Fecal clostridium symbiosum for noninvasive detection of early and advanced colorectal cancer: test and validation studies. EBioMedicine 25:32–40. https://doi.org/10.1016/j.ebiom.2017.10.005
Xu J et al (2020a) Vaginal microbiomes and ovarian cancer: a review. Am J Cancer Res 10(3):743–756
Xu N et al (2020b) Microbiota dysbiosis in lung cancer: evidence of association and potential mechanisms. Transl Lung Cancer Res 9(4):1554–1568. https://doi.org/10.21037/tlcr-20-156
Yachida S et al (2019) Metagenomic and metabolomic analyses reveal distinct stage-specific phenotypes of the gut microbiota in colorectal cancer. Nat Med 25(6):968–976. https://doi.org/10.1038/s41591-019-0458-7
Yang J, Yu J (2021) Relationship between microbiome and colorectal cancer. In: Comprehensive foodomics. Elsevier, Amsterdam, pp 568–578. https://doi.org/10.1016/B978-0-08-100596-5.22881-3
Ye D et al (2019) Significant function and research progress of biomarkers in gastric cancer (Review). Oncol Lett 19:17. https://doi.org/10.3892/ol.2019.11078
Young PE et al (2014) Early detection of colorectal cancer recurrence in patients undergoing surgery with curative intent: current status and challenges. J Cancer 5(4):262–271. https://doi.org/10.7150/jca.7988
Yu L-X, Schwabe RF (2017) The gut microbiome and liver cancer: mechanisms and clinical translation. Nat Rev Gastroenterol Hepatol 14(9):527–539. https://doi.org/10.1038/nrgastro.2017.72
Yu L-X et al (2010) Endotoxin accumulation prevents carcinogen-induced apoptosis and promotes liver tumorigenesis in rodents. Hepatology 52(4):1322–1333. https://doi.org/10.1002/hep.23845
Yu J et al (2017) Metagenomic analysis of faecal microbiome as a tool towards targeted non-invasive biomarkers for colorectal cancer. Gut 66(1):70–78. https://doi.org/10.1136/gutjnl-2015-309800
Yue W et al (2010) Effects of estrogen on breast cancer development: role of estrogen receptor independent mechanisms. Int J Cancer 127(8):1748–1757. https://doi.org/10.1002/ijc.25207
Zackular JP et al (2014) The human gut microbiome as a screening tool for colorectal cancer. Cancer Prev Res 7(11):1112–1121. https://doi.org/10.1158/1940-6207.CAPR-14-0129
Zavoral M (2014) Colorectal cancer screening: 20 years of development and recent progress. World J Gastroenterol 20(14):3825. https://doi.org/10.3748/wjg.v20.i14.3825
Zeng J et al (2020a) Alterations in urobiome in patients with bladder cancer and implications for clinical outcome: a single-institution study. Front Cell Infect Microbiol 10:555508. https://doi.org/10.3389/fcimb.2020.555508
Zeng Y et al (2020b) Gut microbiota dysbiosis in patients with hepatitis B virus–induced chronic liver disease covering chronic hepatitis, liver cirrhosis and hepatocellular carcinoma. J Viral Hepat 27(2):143–155. https://doi.org/10.1111/jvh.13216
Zheng Y et al (2020) Specific gut microbiome signature predicts the early-stage lung cancer. Gut Microbes 11(4):1030–1042. https://doi.org/10.1080/19490976.2020.1737487
Acknowledgment
This work was supported by the National Natural Science Foundation of China (21774039, 51973076), BRICS STI Framework Programme 3rd call 2019 (2018YFE0123700), China Postdoctoral Science Foundation (2016M602291), and the Fundamental Research Funds for Central Universities, Open Research Fund of State Key Laboratory of Polymer Physics and Chemistry, and Changchun Institute of Applied Chemistry, Chinese Academy of Sciences.
Conflict of Interest
All authors declare no competing financial conflict of interest associated with the publication of this work.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Bakadia, B.M. et al. (2022). Microbiome as Cancer Biomarkers. In: Shehzad, A. (eds) Cancer Biomarkers in Diagnosis and Therapeutics. Springer, Singapore. https://doi.org/10.1007/978-981-16-5759-7_5
Download citation
DOI: https://doi.org/10.1007/978-981-16-5759-7_5
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-16-5758-0
Online ISBN: 978-981-16-5759-7
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)